Lexaria Bioscience (LEXX) EBITDA Margin Growth (1y) (2018 - 2026)
Lexaria Bioscience (LEXX) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
-553,266.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
-553,266.00 |
| Aug 31, 2025 |
105,534.00 |
| May 31, 2025 |
-3,374.00 |
| Feb 28, 2025 |
-114,886.00 |
| Nov 30, 2024 |
-69,506.00 |
| Aug 31, 2024 |
143,299.00 |
| May 31, 2024 |
92,932.00 |
| Feb 29, 2024 |
601,735.00 |
| Nov 30, 2023 |
101,995.00 |
| Aug 31, 2023 |
-351,094.00 |
| May 31, 2023 |
-62,665.00 |
| Feb 28, 2023 |
-175,605.00 |
| Nov 30, 2022 |
1.26 Mn |
| Aug 31, 2022 |
-49,990.00 |
| May 31, 2022 |
-118,111.00 |
| Feb 28, 2022 |
-416,580.00 |
| Nov 30, 2021 |
-1.43 Mn |
| Aug 31, 2021 |
128,253.00 |
| May 31, 2021 |
255,072.00 |
| Feb 28, 2021 |
219,142.00 |
